Ranolazine Prevents Heart Failure with Preserved Ejection Fraction; Diastolic Dysfunction and Left Ventricular Hypertrophy in a Hypertensive Murine Model

被引:0
|
作者
Valadri, R.
Gadesam, R.
Onwuanyi, A.
Fan, M. T.
Bloom, H.
机构
关键词
D O I
10.1016/j.cardfail.2011.06.043
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S13 / S13
页数:1
相关论文
共 50 条
  • [31] Diastolic Ventricular Interaction in Heart Failure With Preserved Ejection Fraction
    Parasuraman, Sathish K.
    Loudon, Brodie L.
    Lowery, Crystal
    Cameron, Donnie
    Singh, Satnam
    Schwarz, Konstantin
    Gollop, Nicholas D.
    Rudd, Amelia
    McKiddie, Fergus
    Phillips, Jim J.
    Prasad, Sanjay K.
    Wilson, Andrew M.
    Sen-Chowdhry, Srijita
    Clark, Allan
    Vassiliou, Vassilios S.
    Dawson, Dana K.
    Frenneaux, Michael P.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (07):
  • [32] T Cells Contribute To Diastolic Dysfunction And Cardiac Hypertrophy In A Preclinical Model Of Heart Failure With Preserved Ejection Fraction
    Smolgovsky, Sasha
    Carrillo-Salinas, Francisco
    Anastasiou, Marina
    Kaur, Kuljeet
    Bayer, Abraham
    Aronovitz, Mark
    Blanton, Robert M.
    Alcaide, Pilar
    CIRCULATION RESEARCH, 2021, 129
  • [33] Left ventricular fibrosis and hypertrophy are associated with mortality in heart failure with preserved ejection fraction
    Garg, Pankaj
    Assadi, Hosamadin
    Jones, Rachel
    Chan, Wei Bin
    Metherall, Peter
    Thomas, Richard
    van der Geest, Rob
    Swift, Andrew J.
    Al-Mohammad, Abdallah
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [34] ALPK2 prevents cardiac diastolic dysfunction in heart failure with preserved ejection fraction
    Yoshida, Tatsuya
    Yoshida, Satoya
    Inukai, Kohei
    Kato, Katsuhiro
    Yura, Yoshimitsu
    Hattori, Tomoki
    Taki, Kentaro
    Enomoto, Atsushi
    Ohashi, Koji
    Okumura, Takahiro
    Ouchi, Noriyuki
    Kawase, Haruya
    Wettschureck, Nina
    Offermanns, Stefan
    Murohara, Toyoaki
    Takefuji, Mikito
    FASEB JOURNAL, 2024, 38 (22):
  • [35] Effects of spironolactone on the left ventricular hypertrophy in chronic heart failure with preserved ejection fraction
    Karapysh, V. A.
    Vatutin, N. T.
    Shevelok, A. N.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 48 - 48
  • [36] A rare genetic cause of left ventricular hypertrophy and heart failure with preserved ejection fraction
    Gruebler, M.
    Zach, D.
    Hoeller, V
    Seebacher, H. A.
    Verheyen, N.
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (SUPPL 2) : 129 - 129
  • [37] Left ventricular fibrosis and hypertrophy are associated with mortality in heart failure with preserved ejection fraction
    Pankaj Garg
    Hosamadin Assadi
    Rachel Jones
    Wei Bin Chan
    Peter Metherall
    Richard Thomas
    Rob van der Geest
    Andrew J. Swift
    Abdallah Al-Mohammad
    Scientific Reports, 11
  • [38] Interleukin-18 Blockade Prevents Diastolic Dysfunction in a Mouse Model of Heart Failure With Preserved Ejection Fraction
    Regan, Jessica A.
    Mauro, Adolofo G.
    Carbone, Salvatore
    Marchetti, Carlo
    Mezzaroma, Eleonora
    Krauskaus, Donatas
    Salloum, Fadi N.
    Dinarello, Charles A.
    Van Tassel, Benjamin
    Abbate, Antonio
    Toldo, Stefano
    CIRCULATION, 2015, 132
  • [39] Left ventricular diastolic dysfunction in dialysis patients with preserved ejection fraction
    Cafka, M.
    Rroji, M.
    Seferi, S.
    Burazeri, G.
    Seiti, J.
    Goda, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 97 - 97
  • [40] Rosuvastatin improves diastolic stiffness in heart failure with preserved ejection fraction in hypertensive rat even after development of ventricular hypertrophy
    Chang, Sung-A
    Lee, Hye-Won
    Kim, Song-Yi
    Kwon, Dong-A
    Chang, Hyuk-Jae
    Kim, Yong-Jin
    Sohn, Dae-Won
    Oh, Byung-Hee
    Park, Young-Bae
    Choi, Yun-Shik
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A377 - A377